Changing the treatment paradigm of hyperkalaemia management to enable and optimize renin-angiotensin-aldosterone system inhibitors therapy.
27 May 2018 (13:05 - 13:20)
Organised by:
About the speaker
University of Michigan, Ann Arbor (United States of America)
4 More presentations in this session
Professor J. Cleland (Glasgow, GB)
Professor P. Van Der Meer (Groningen, NL)
Professor J. Cleland (Glasgow, GB)
Access the full session
The Event
Heart Failure 2018
27 May 2018
13:05 CET
You may be interested in
Congress Presentation
Congress Presentation
Congress Presentation
Congress Session
